Shares of Teleflex Incorporated (NYSE:TFX - Get Free Report) have earned a consensus rating of "Moderate Buy" from the seven analysts that are covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $252.50.
Several analysts recently weighed in on TFX shares. StockNews.com raised shares of Teleflex from a "hold" rating to a "buy" rating in a research note on Thursday, November 28th. Truist Financial reduced their price target on Teleflex from $227.00 to $200.00 and set a "hold" rating on the stock in a research report on Wednesday, December 18th. Needham & Company LLC restated a "hold" rating on shares of Teleflex in a research report on Monday, December 16th. Royal Bank of Canada reduced their target price on Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a report on Friday, November 1st. Finally, Mizuho lowered their price target on shares of Teleflex from $275.00 to $250.00 and set a "neutral" rating for the company in a report on Friday, November 1st.
Read Our Latest Stock Analysis on TFX
Institutional Investors Weigh In On Teleflex
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Cromwell Holdings LLC grew its stake in shares of Teleflex by 59.0% in the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company's stock valued at $33,000 after buying an additional 49 shares during the period. Avior Wealth Management LLC grew its stake in Teleflex by 190.6% in the third quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company's stock valued at $38,000 after acquiring an additional 101 shares during the period. Ashton Thomas Securities LLC bought a new stake in shares of Teleflex during the third quarter valued at approximately $40,000. True Wealth Design LLC raised its position in shares of Teleflex by 16,600.0% during the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company's stock worth $41,000 after purchasing an additional 166 shares during the period. Finally, Canada Pension Plan Investment Board bought a new position in shares of Teleflex in the 2nd quarter worth $42,000. 95.62% of the stock is owned by institutional investors.
Teleflex Price Performance
Shares of NYSE TFX traded up $0.11 during mid-day trading on Friday, hitting $181.56. 589,843 shares of the stock traded hands, compared to its average volume of 391,622. The company has a market cap of $8.43 billion, a PE ratio of 36.10, a price-to-earnings-growth ratio of 1.64 and a beta of 1.16. Teleflex has a twelve month low of $171.69 and a twelve month high of $256.85. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The firm has a 50 day simple moving average of $184.14 and a two-hundred day simple moving average of $215.49.
Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.38 by $0.11. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $764.40 million during the quarter, compared to analyst estimates of $768.68 million. During the same quarter last year, the business earned $3.64 EPS. The firm's quarterly revenue was up 2.4% on a year-over-year basis. As a group, equities research analysts forecast that Teleflex will post 13.98 EPS for the current fiscal year.
Teleflex Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Monday, December 16th. Investors of record on Friday, November 15th were paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.75%. The ex-dividend date of this dividend was Friday, November 15th. Teleflex's dividend payout ratio is presently 27.04%.
Teleflex Company Profile
(
Get Free ReportTeleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Featured Articles
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.